With regard to pharmaceutical drugs, treatments and therapies authorized by Health Canada since January 1, 2020: (a) how many pharmaceutical drugs (or new drug submissions) were granted authorization; (b) what are the details of each drug in (a), including the (i) name of the drug, (ii) date of the approval, (iii) purpose of the drug, including the disease or condition treated by drug; and (c) of the pharmaceutical drugs listed in (b), how many and which ones were for treatments or therapies for rare diseases, known as orphan drugs?
In the House of Commons on January 31st, 2022. See this statement in context.